1)Cimmino MA, et al : The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. BMC Musculoskelet Disord 12(1) : 94, 2011. PMID 21569559
2)Kimura M, et al : Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica. J Rheumatol 39(1) : 148-153, 2012. PMID 22174210
3)Smets P, et al : Vascular endothelial growth factor levels and rheumatic diseases of the elderly. Arthritis Res Ther 18(1) : 283, 2016. PMID 27906058
1)Olivé A, et al : The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema ; The Catalán Group for the Study of RS3PE. J Rheumatol 24(2) : 333-336, 1997. PMID 9034993
2)McCarty DJ, et al : Remitting seronegative symmetrical synovitis with pitting edema ; RS3PE syndrome. JAMA 254(19) : 2763-2767, 1985. PMID 4057484
3)Kimura M, et al : Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica.J Rheumatol 39(1) : 148-153, 2012. PMID 22174210
4) Fabrizio C, et al : Remitting seronegative symmetrical synovitis with pitting odema(RS3PE) syndorome ; a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis 58(4) : 230-236, 1999. PMID 10364902
5)Quick V, et al : Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell(temporal) arteritis. J R Coll Physicians Edinb 42(4) : 341-349, 2012. PMID 23240123